News Copaxone first on FDA's list for faster complex generic appr... Teva will attempt to block generic launch in courts
News Huntington's Disease wearable gets backing from NIH BioSensics' HDWear provides real-time motor function scores in Huntington's patients.
News Teva sells women's health division to tackle $35bn debts Teva has sold its women’s health business in order to pay off some of its $35 billion in debts built up in acquiring Allergan’s generics business.
News Teva appoints Lundbeck's Kare Schultz as CEO Unlike AZ's Soriot, Schultz "couldn't refuse" top job at Teva.
News Bidders lining up for Teva women's health unit Allergan generics buyout left Teva with $35m debts
News Roche's Herceptin facing further biosimilar threats in US Breast cancer blockbuster facing potential trio of US competitors.
Digital On AI and computational support of biochemistry, with Alan R... Dr Alan Roth, CEO of Oxford Drug Design, discusses the use of AI to accelerate discovery of new treatments.
Sales & Marketing Sponsored The AI imperative: Establishing the standard for modern clin... The findings from the Medidata-commissioned survey confirm that AI implementation in clinical trials has moved firmly beyond theoretical discussion.
